(Date:12/11/2009)... Biosciences Corporation announced today the enrollment and dosing at ... of the first patient in the ACE ( ... Phase 2 pivotal trial in patients with relapsed or ... novel, orally available, potent and highly selective small molecule ... (FLT3) inhibitor. The ACE study is designed to ...
(Date:12/11/2009)... /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. (TSX:ONC, NASDAQ: ONCY ... appointment of Dr. Alan Warrander to the role ... Development. ,, "Dr. Warrander will be responsible for ... REOLYSIN(R)," said Dr. Brad Thompson, President and CEO ... design of a Phase 3 trial examining REOLYSIN ...
(Date:12/10/2009)... 10 Endologix, Inc. (Nasdaq: ELGX ... disorders, announced today that Dan Lemaitre, former President ... Board of Directors effective December 11, 2009. ... non-independent directors. ,, Franklin D. Brown, Chairman of ... Dan Lemaitre to the Endologix Board of Directors. ...
(Date:12/10/2009)... MISSISSAUGA, ON, Dec. 10 /PRNewswire-FirstCall/ - YM BioSciences ... a life sciences product development company that identifies ... products at various stages of development, today provided ... result in the merger of Cytopia Ltd. into ... 5, 2009. The board of directors of Cytopia ...
Breaking Biology Technology:Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 2Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 3Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 4Ambit Biosciences Initiates First Phase 2 Clinical Trial of AC220 in Acute Myeloid Leukemia 5Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 2Oncolytics Biotech(R) Inc. Appoints Senior Vice President, Global Licensing and Business Development 3Endologix Appoints Dan Lemaitre to its Board of Directors 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 2YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 3YM BIOSCIENCES OFFER FOR CYTOPIA APPROVED TO PROCEED TO SHAREHOLDER VOTE BY AUSTRALIAN COURT 4... (GPhA) President and CEO Kathleen Jaeger today,released the ... on their efforts to improve the generic drug,approval ... of increasing efficiency in the generic,approval system, another ... the,job done. What consumers need is for the ...
... N.J., Oct. 4 Vicus Therapeutics, LLC, an,oncology-focused, ... and Chief Executive Officer, will,participate in two panel ... an Industry Perspective" and "Exit Strategies:,Managing Risk and ... 2007. The,sessions will run from 9:00 a.m. to ...
... CALGARY, Oct. 4 /PRNewswire-FirstCall/ - Ms. Mary Ann Dillahunty, ... ONCY), will present a corporate overview of the Company ... p.m. PT. The conference,will be held at the Palace ... A live audio link to the webcast presentation is ...
Other Biology Technology:Statement from GPhA President and CEO Kathleen Jaeger on FDA's Generic Initiative 2Vicus Therapeutics' Chief Executive Officer to Participate in BIOTECH 2007 Expert Panels 2Media Advisory - Oncolytics Biotech Inc. to Present at BIO InvestorForum 2007 2... Max Planck researchers in Bad Nauheim discover the mechanism ... or heart muscle tissue. ,There is disagreement, however, about ... from the Max Planck Institute for Heart and Lung ... from Martin Luther University in Halle-Wittenberg, have now shown ...
... Energy's (DOE) Office of Science has established a ... of Hurricane Katrina. , "Our colleagues in science ... Dr. Raymond L. Orbach, director of DOE's Office ... to: universities and colleges, including those in ...
... by manipulating the mosquitoes' sense of smell is the ... University, that has been selected to receive $8.5 million ... , The initiative, which was launched by the Bill ... of 43 "groundbreaking" research projects to improve health in ...
Other Biology News:Tissue regeneration operates differently than expected 2Tissue regeneration operates differently than expected 3DOE's Office of Science sets up program to aid scientists displaced by Hurricane Katrina 2Fighting malaria by manipulating mosquitoes' sense of smell 2Fighting malaria by manipulating mosquitoes' sense of smell 3... DNA Engine Dyad thermal cycler is ... (PCR). The chassis accommodates a variety ... assemblies), which hold different types and ... graphical programming with point-and-click navigation. Peltier ...
... IHC Select Immunophosphatase Secondary Detection System is ... Select Prediluted Primary Antibody reagents, which contain ... identification of antigens by light microscopy in ... Detection System may also be used with ...
... FLISP Assay with SR-101 Labeled Substrates ... • Accurately measure serine protease activation ... • B-Bridge's FLISP Kits utilize cell-permeable, ... (FLISPs) to measure chymotrypsin-like activity in ...
From the company that first brought you the chromatin immunoprecipitation (ChIP) kit, a new and improved kit, EZ-ChIP, is now available to make your experiments easier, quicker, and most importantly,...
Biology Products:Biology NavigationMedical Navigation